Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure

Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure

Background: According to numerous studies, from 30% to 50% of patients with chronic heart failure (CHF) are resistant to cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM), despite their careful selection in accordance with current guidelines. It is of interest to stu...

Full description

Bibliographic Details
Main Authors: N. B. Shlevkov, A. Zh. Gasparyan, A. A. Zhambeev, H. F. Salami, E. V. Guseva, G. S. Tarasovskiy, T. V. Sharf, O. V. Stukalova, E. M. Gupalo, N. A. Mironova, A. A. Skvortsov, S. P. Golitsyn
Format: Article
Language:Russian
Published: MONIKI 2021-06-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
biomarkers
nt-probnp
sst2
chronic heart failure
cardiac resynchronization therapy
cardiac contractility modulation
prognosis
Online Access:https://www.almclinmed.ru/jour/article/view/1487

Internet

https://www.almclinmed.ru/jour/article/view/1487

Similar Items